V0131552

INLURIYO

:
Orðmerki
:
Skráð

23.8.2023
15.11.2023
15.01.2024
15.1.2024
23.8.2033
  • :
    23.8.2023
  • :
    15.11.2023
  • :
    15.1.2024
  • :
    15.1.2024
  • :
    V0131552
  • :
    Eli Lilly and Company
  • :
    Lilly Corporate Center, Indianapolis, Indiana 46285, US
  • :
    Lára Helga Sveinsdóttir
  • :
    Grundarstíg 23, 101 Reykjavík, Íslandi
  • 5

    Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson’s disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; pharmaceutical preparations.